Palantir has seen its portfolio of government contracts mushroom in President Trump’s second term, but the company is also ...
ScinoPharm Taiwan (TWSE: 1789) today announced a landmark achievement in the global pharmaceutical landscape, securing U.S. Food and Drug Administration (FDA) approval for Glatiramer Acetate Injection ...